US legislative update: takeaways for European pharma
Keith A Zullow and Jenny J Zhang examine upcoming US pharmaceutical regulation and how, if passed, it could impact European pharma/biopharma.
Source: europeanpharmaceuticalreview.com
📰 Stop Stalling Access News
Stop Stalling Access News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Stop Stalling Access. Real-time updates on events, politics, business and more.
Updates on Pending Legislation: Citizen Petitions | Goodwin
The Big Molecule Watch is monitoring pending legislation in Congress that relates to biosimilars and biologics. In this post, we check in on the status of two currently pending bills...
House Judiciary Committee On Senate Health Big Molecule Watch Stop Stalling Access Affordable Medications Federal Trade Commission
Source: jdsupra.com
Biosimilars 2021 Year in Review | Fish & Richardson
2021 saw several important milestones in the biosimilars space, including the much anticipated first interchangeable designations by FDA and the approval of the first ophthalmology...
Source: jdsupra.com
Healthcare Roundup: October 1, 2021 - Food, Drugs, Healthcare, Life Sciences
Congress passed – and the President signed into law – a short-term continuing resolution (CR) to avoid a government shutdown and fund government operations through December 3...
United States District Of Columbia Brian Fitzpatrick Jaime Herrera Beutler Nancy Pelosi Senate Republicans
Source: mondaq.com